A detailed history of Profund Advisors LLC transactions in Geron Corp stock. As of the latest transaction made, Profund Advisors LLC holds 281,519 shares of GERN stock, worth $1.13 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
281,519
Previous 183,256 53.62%
Holding current value
$1.13 Million
Previous $777,000 64.48%
% of portfolio
0.05%
Previous 0.03%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.17 - $4.99 $409,756 - $490,332
98,263 Added 53.62%
281,519 $1.28 Million
Q2 2024

Aug 13, 2024

SELL
$3.1 - $5.09 $598,622 - $982,899
-193,104 Reduced 51.31%
183,256 $777,000
Q1 2024

May 08, 2024

BUY
$1.75 - $3.44 $175,939 - $345,847
100,537 Added 36.45%
376,360 $1.24 Million
Q4 2023

Feb 14, 2024

SELL
$1.74 - $2.31 $81,839 - $108,648
-47,034 Reduced 14.57%
275,823 $581,000
Q3 2023

Nov 13, 2023

BUY
$2.11 - $3.28 $163,936 - $254,839
77,695 Added 31.69%
322,857 $684,000
Q2 2023

Aug 10, 2023

SELL
$1.97 - $3.69 $193,926 - $363,243
-98,440 Reduced 28.65%
245,162 $786,000
Q1 2023

May 11, 2023

BUY
$2.14 - $3.4 $735,308 - $1.17 Million
343,602 New
343,602 $745,000
Q1 2022

May 10, 2022

SELL
$0.99 - $1.6 $10,207 - $16,497
-10,311 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$1.22 - $1.72 $12,579 - $17,734
10,311 New
10,311 $13,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.52B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.